VILAINTRA-TRIO LIFE CAPS
MRP: 1,200
Packaging: 30 caps
Pack Type: life-caps
Composition:
Vilanterol 25mcg + Fluticasone 100 mcg + umeclidinium bromide 62.5 mcg trifenatate powder
Indication:
For the maintenance treatment of COPD, including chronic bronchitis and emphysema, to improve airflow and reduce breathing difficulty.
Description:
Vilanterol 25 mcg + Fluticasone 100 mcg + Umeclidinium Bromide 62.5 mcg (Trifenatate) Powder for Inhalation is a triple combination respiratory therapy indicated for the long-term maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD) and in certain cases of asthma where triple therapy is recommended.
This formulation combines three pharmacological classes:
Vilanterol (LABA) – Long-acting β2-agonist that relaxes airway smooth muscles.
Fluticasone (ICS) – Inhaled corticosteroid that reduces airway inflammation.
Umeclidinium (LAMA) – Long-acting muscarinic antagonist that prevents bronchoconstriction.
Together, these agents improve lung function, reduce exacerbations, enhance airflow, and provide 24-hour bronchodilation when used regularly as prescribed.
This triple therapy is especially beneficial for patients with persistent symptoms despite dual therapy and for those with frequent COPD exacerbations.
Tags:
- Provides 24-hour bronchodilation
- Reduces COPD exacerbations
- Improves breathing and airflow
- Decreases airway inflammation
- Enhances exercise tolerance
- Improves quality of life
- Once-daily convenient dosing
Usage Information
Dosage
Recommended Dose: One inhalation once daily at the same time each day. For inhalation use only. Do not exceed the prescribed dose. Rinse mouth with water after use to reduce the risk of oral thrush. ⚠ Use regularly for maintenance therapy. Not indicated for acute bronchospasm relief.
Side Effects
Headache Nasopharyngitis Cough Dry mouth Oral candidiasis (thrush) Palpitations Tremor Urinary retention (rare) Seek medical attention if severe allergic reactions or worsening breathing occur.
Contraindications
Hypersensitivity to any component Severe milk protein allergy (if applicable to device) Acute bronchospasm Untreated fungal, viral, or bacterial respiratory infections Use with caution in: Cardiovascular disorders Glaucoma Prostatic hyperplasia Thyroid disorders
Availability
Triple therapy inhaler, Vilanterol Fluticasone Umeclidinium powder, COPD maintenance inhaler, LABA LAMA ICS combination, COPD triple inhaler therapy, long acting bronchodilator inhaler, once daily COPD inhaler, asthma triple therapy inhalation powder